|
Characteristic
|
Total (N = 18)
|
|---|
|
Sex, n (%)
|
|
Male
|
12 (66.7)
|
|
Female
|
6 (33.3)
|
|
Age (mean), years
|
49.1
|
|
Median (range)
|
49.5 (23–65)
|
|
ECOG performance status, n (%)
|
|
0
|
8 (44.4)
|
|
1
|
10 (55.6)
|
|
TNM stage, n (%)
|
|
IIIA
|
1 (6)
|
|
IV
|
17 (94)
|
|
Previous regimens of systemic therapies
|
|
Median (range)
|
3.5 (1–9)
|
|
Tumor type, n (%)
|
|
NSCLC
|
5 (27.8)
|
|
Colorectal cancer
|
7 (38.9)
|
|
Ovarian cancer
|
1 (5.6)
|
|
Gastric cancer
|
1 (5.6)
|
|
Thyroid cancer
|
1 (5.6)
| |
|
DLBCL
|
1 (5.6)
| |
|
Fibrosarcoma
|
1 (5.6)
| |
|
Renal cancer
|
1 (5.6)
| |
- ECOG Eastern Cooperative Oncology Group, NSCLC non-small-cell lung cancer, DLBCL diffuse large B cell lymphoma
